Actinomycetales infectious disease

Summary

Actinomycetales infectious disease (MONDO:0006921) is a disease. A subtype of gram-positive bacterial infections — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Actinomycetales infectious disease
Mondo ID	MONDO:0006921
EFO	EFO:1001122
MeSH	D000193
NCIT	C84534
SNOMED CT	11817007, 721751007
UMLS	C0001255
MedGen	1732
Is cancer (heuristic)	no

Also known as: actinomycetales caused disease or disorder · actinomycetales disease or disorder · actinomycetales infection · actinomycetales infections · actinomycete infection · actinomycete infections · actinomycotic infection · actinomycotic infectious disease · infection caused by actinomycetales · infection, actinomycetales · infection, actinomycete · infections, actinomycetales · infections, actinomycete

Disease family

This is a subtype of gram-positive bacterial infections. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › gram-positive bacterial infections › Actinomycetales infectious disease

Related subtypes (5): Erysipelothrix infectious disease, Bacillaceae infectious disease, streptococcal infection, Clostridium infectious disease, infection caused by Bifidobacterium

Subtypes (1): actinomycosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.